Form 13-F position report

NANOVIBRONIX INC

Reported by MORGAN STANLEY

NAOV CUSIP 63008J603 Manager CIK 0000895421

First reported at 10 shares this quarter.

New
% of reported 13F value < 0.01% This manager · Q1 2023
Shares 10 Quarter-end amount reported
Reported value $34 Fair value at quarter end
Consecutive quarters held 7 Through Q1 2023

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 114000
2022-03-31 0
2022-06-30 0
2022-09-30 0
2022-12-31 50
2023-03-31 0
2023-03-31 34
2023-06-30 34
2023-09-30 20
2023-12-31 12
2024-03-31 9
2024-06-30 0
2025-03-31 46427
2025-06-30 954
2025-09-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

15 quarters
Quarterly reported position history for NANOVIBRONIX INC held by MORGAN STANLEY.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2025 Reduced 0 -1,029 (-100.0%) 0 $0 2025-11-14
Q2 2025 Reduced 1,029 -12,586 (-92.4%) < 0.01% $954 2025-08-15
Q1 2025 New 13,615 +13,615 (0.0%) < 0.01% $46,427 2025-05-15
Q2 2024 Reduced 0 -10 (-100.0%) 0 $0 2024-08-14
Q1 2024 Unchanged 10 0 (0.0%) < 0.01% $9 2024-05-15
Q4 2023 Unchanged 10 0 (0.0%) < 0.01% $12 2024-02-13
Q3 2023 Unchanged 10 0 (0.0%) < 0.01% $20 2023-11-15
Q2 2023 Unchanged 10 0 (0.0%) < 0.01% $34 2023-08-14
Q1 2023 New 10 +10 (0.0%) < 0.01% $34 2023-05-15
Q1 2023 Reduced 0 -200 (-100.0%) 0 $0 2023-05-15
Q4 2022 Unchanged 200 0 (0.0%) < 0.01% $50 2023-02-14
Q3 2022 Unchanged 200 0 (0.0%) 0 $0 2022-11-14
Q2 2022 Added 200 +193 (2757.1%) 0 $0 2022-08-15
Q1 2022 Reduced 7 -109,152 (-100.0%) 0 $0 2022-05-13
Q4 2021 Added 109,159 +89,583 (457.6%) < 0.01% $114,000 2022-02-14
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

10 managers reported NANOVIBRONIX INC for Q1 2023.

Managers reporting NANOVIBRONIX INC in Q1 2023.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC New 31,682 +31,682 < 0.01% $108,669 1 qtr
Amtrust Financial Services Inc New 12,407 +12,407 0.02% $42,559 1 qtr
GEODE CAPITAL MANAGEMENT LLC New 10,721 +10,721 < 0.01% $36,236 1 qtr
UBS Group AG New 3,669 +3,669 < 0.01% $12,585 1 qtr
Tower Research Capital LLC TRC New 806 +806 < 0.01% $3,000 1 qtr
BlackRock Inc New 74 +74 < 0.01% $254 1 qtr
Bank of America Corporation New 64 +64 < 0.01% $220 1 qtr
WELLS FARGO & COMPANY MN New 11 +11 < 0.01% $38 1 qtr
MORGAN STANLEY This report New 10 +10 < 0.01% $34 1 qtr
NewSquare Capital LLC New 10 +10 < 0.01% $34 1 qtr
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2023
Filed
May 15, 2023
Filing type
13F-HR
Position type
COM NEW

Voting authority reported

Sole
0
Shared
0
None
10

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.